SEC 13F Intelligence

Mpm Bioimpact LLC / CLYM

Mpm Bioimpact LLC’s Climb Bio Inc Position

Does Mpm Bioimpact LLC own Climb Bio Inc (CLYM)? Yes2.59M shares worth $18M (+1.37% of its 13F portfolio) as of Q1 2026, down from 2.67M shares the prior filed quarter.

Position Value
$18M
Q1 2026
Shares
2.59M
% of Portfolio
+1.37%
Quarters Held
2
currently held

Position History CLYM

Reported value by quarter
Q4 ’25: $11MQ4 ’25Q1 ’26: $18MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.59M$18M+1.37%
Q4 20252.67M$11M+1.22%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of CLYM.